Daniel R. Kuritzkes

1. Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis
   2021/03/17 by Amy G. Cutrell, Amy Cutrell, Jonathan M. Schapiro +28 · 8 citations
   Immunology and Microbiology · Medicine · #HIV Research and Treatment #HIV-related health complications and treatments #HIV/AIDS drug development and treatment
2. Comparison of Sequencing by Hybridization and Cycle Sequencing for Genotyping of Human Immunodeficiency Virus Type 1 Reverse Transcriptase
   2000/07/01 by George J. Hanna, Victoria A. Johnson, Daniel R. Kuritzkes +5 · 2 citations
   Immunology and Microbiology · Medicine · Biochemistry, Genetics and Molecular Biology · #HIV Research and Treatment #HIV/AIDS drug development and treatment #Biochemical and Molecular Research #Reverse transcriptase #Genotyping #Biology #Virology #Human immunodeficiency virus (HIV) #DNA sequencing #Polymerase chain reaction #Genetics #Genotype #DNA #Gene
3. Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
   2022/05/14 by Catia Marzolini, Daniel R. Kuritzkes, Fiona Marra +9 · 1 citation
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Drug-Induced Hepatotoxicity and Protection #Inflammatory mediators and NSAID effects #Pharmacogenetics and Drug Metabolism